Cutaneous leishmaniasis: treatment with ketoconazole.
A 17-year-old boy with an eight-month history of cutaneous leishmaniasis on the left earlobe was treated with ketoconazole for a period of four weeks. The patient showed excellent improvement both clinically and protozoologically. Ketoconazole, a new imidazole bound covalently to piperazine, has been developed as a broad spectrum antimycotic agent and appears to be a good antileishmanial drug.
D000293:Adolescent; D004431:Ear, External; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use*; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male
D007654:Ketoconazole